WE ARE NO LONGER ACCEPTING PROPECIA CASES
Hair loss is a common occurrence, most often experienced by men as they age. To combat hair loss and baldness, Propecia (finasteride) for men prevents the conversion of testosterone to dihydrotestosterone. Manufactured by the pharmaceutical giant Merck & Co., Propecia was immediately a hit amongst balding men upon its release. However, Propecia can result in adverse sexual and health side effects for patients, and can be dangerous for women and children who are exposed to the drug.
Side Effects of Propecia
The adverse side effects of Propecia for men are many. These include:
- Decreased libido;
- Erectile dysfunction;
- Depressive symptoms; and
- Suicidal thoughts;
- Increased risk of prostate cancer; and
- Increased risk of breast cancer.
The above risks are not the only ones associated with the drug; Propecia can also be dangerous for women and children who are exposed to it. In fact, there is evidence to suggest that Propecia may cause birth defects in the fetus of a woman who is exposed to Propecia during pregnancy.
While Merck & Co. published some of these risks when Propecia was released, other risks were not made known. Furthermore, the fact that certain side effects could continue even when a person stopped taking Propecia was not published.
Filing a Lawsuit against Merck & Co.
Because Merck & Co. did not fully disclose the dangers associated with taking or being exposed to Propecia, the drug manufacturing company violated its duty of care to the consumer. As such, the company may be held liable for all harm that a patient experiences as a direct result of taking the drug. If you have suffered adverse effects due to taking Propecia, you may have a cause of action against Merck & Co.
Consult with a Pharmaceutical Litigation Attorney Today
A consultation with the experienced pharmaceutical litigation attorneys at Napoli Shkolnik, PLLC can help you recover damages for the harm that you have suffered. To learn more, contact our team today by calling our offices at your earliest convenience.